OHSU scientist John Williams puts the complex functions of the human brain on opioids into very straightforward language. Check out this Q&A by Oregonian reporter Lynne Terry.
Worried about someone who is using methamphetamine? Worried about YOUR use? Researchers at CODA are conducting a voluntary research study for adults ages 18 to 65. The no-cost treatment may include a placebo. Eligible participants …
CODA, Central City Concern, collaborate in groundbreaking Wheelhouse network
Health Share of Oregon has made possible the innovative Wheelhouse network to bring Medication Assisted Treatment to more people in our community. Check out this video and press release to learn more!
Governor Kate Brown’s Opioid Epidemic Task Force is holding its first meeting today, September 19! Gov. Brown is also signing House Bill 3440, a comprehensive bill that removes barriers the lifesaving overdose drug Naloxone, improves access …
12 steps in Iran: How AA is changing society and health
The New York Times takes a fascinating look at the emergence of Alcoholics Anonymous in Iran. Moving from a culture in which beatings are the go-to approach for substance use disorders involving alcohol, a new …
Have you seen the latest Health Share of Oregon video about Project Nurture? Check it out! CODA is very proud to work with the new moms and pregnant women in medication-assisted treatment who come to …
Rhode Island brings evidence-based treatment to all prison inmates
The state of Rhode Island is putting medication-assisted treatment in reach of all prison inmates! Evidence-based treatment — the science that helps CODA patients every day — is helping people there rebuild their lives in …
CODA is very proud to be a recipient of a GROW grant from Advantis Credit Union. More than 20,000 votes were cast to determine which seven nonprofit organizations would be selected to receive a grant …
CODA Research is involved in two National Institute on Drug Abuse new studies. The links to these two trials are below: “Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder. “ “Lorcaserin in …
Dr. Honora Englander honored at the WE ARE CODA Advocacy Awards luncheon
Dr. Honora Englander, MD, FACP, Director/PI, Improving Addiction Care Team (Project IMPACT) at Oregon Health & Science University, was honored at this year’s event on April 4. Check out the terrific coverage in Portland’s Society …
All too often, substance use disorders can be viewed as health challenges that exist separately from other conditions. SAMHSA (the federal Substance Use and Mental Health Services Administration) has been a partner in the Million …